ETH Zürich
Dr. Pavel Sergeev serves as the CEO of a Pharmaceutical Company since 2010, where notable achievements include transforming the company into a leader in the anticancer drug sector. Concurrently, Dr. Sergeev has held the position of Senior Scientist at ETHZ since June 2005, contributing significant expertise to the field. Prior to these roles, Dr. Sergeev worked as a Senior Scientist at the University of Zurich from 1995 to 2005, focusing on molecular biological studies.
This person is not in any teams
This person is not in any offices
ETH Zürich
9 followers
Freedom and individual responsibility, entrepreneurial spirit and open-mindedness: ETH Zurich stands on a bedrock of true Swiss values. Our university for science and technology dates back to the year 1855, when the founders of modern-day Switzerland created it as a centre of innovation and knowledge. At ETH Zurich, students discover an ideal environment for independent thinking, researchers a climate which in-spires top performance. Situated in the heart of Europe, yet forging connections all over the world, ETH Zurich is pioneering effective solutions to the global challenges of today and tomorrow.